A. Kopp

发表

Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity

C. Buechler, J. Wanninger, M. Neumeier, 2009, European journal of clinical investigation.

J. Schölmerich, C. Buechler, W. Falk, 2010, Endocrinology.

Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes

J. Schölmerich, C. Buechler, M. Neumeier, 2006, Cardiovascular diabetology.

Innate Immunity and Adipocyte Function: Ligand‐specific Activation of Multiple Toll‐like Receptors Modulates Cytokine, Adipokine, and Chemokine Secretion in Adipocytes

C. Buechler, J. Schölmerich, M. Neumeier, 2009, Obesity.

Fatty acid‐induced induction of Toll‐like receptor‐4/nuclear factor‐κB pathway in adipocytes links nutritional signalling with innate immunity

C. Buechler, W. Falk, M. Neumeier, 2009, Immunology.

Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complications.

C. Buechler, H. Herfarth, A. Schäffler, 2012, Experimental and molecular pathology.

Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes

C. Buechler, J. Wanninger, M. Neumeier, 2008, FEBS letters.

Adiponectin downregulates galectin‐3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes

C. Buechler, J. Wanninger, M. Neumeier, 2009, FEBS letters.

Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3.

C. Buechler, J. Schölmerich, M. Neumeier, 2010, Endocrinology.

Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus.

J. Schölmerich, M. Neumeier, C. Aslanidis, 2010, Cytokine.

Alpha-syntrophin deficient mice are protected from adipocyte hypertrophy and ectopic triglyceride deposition in obesity.

C. Buechler, Kristina Eisinger, G. Liebisch, 2018, Experimental and molecular pathology.

Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.

Sabrina Bauer, C. Buechler, J. Wanninger, 2011, Experimental and molecular pathology.

A. Schäffler, F. Hanses, A. Schmid, 2014, Biochemical and biophysical research communications.

Regulation and function of C1Q/TNF-related protein-5 (CTRP-5) in the context of adipocyte biology.

M. Wabitsch, M. Müller, C. Aslanidis, 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

The novel adipokine C1q/TNF-related protein-3 is expressed in human adipocytes and regulated by metabolic and infection-related parameters.

M. Müller, A. Schäffler, F. Hanses, 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.

H. Brühl, Sabrina Bauer, C. Buechler, 2011, Cytokine.

Splanchnic concentrations and postprandial release of visceral adipokines.

J. Schölmerich, R. Wiest, A. Schäffler, 2010, Metabolism: clinical and experimental.

In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).

C. Buechler, A. Schäffler, F. Hanses, 2011, The Journal of clinical endocrinology and metabolism.

Peritoneal fluid adipokines: ready for prime time?

C. Buechler, M. Neumeier, R. Wiest, 2009, European journal of clinical investigation.

Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics.

Sabrina Bauer, C. Buechler, J. Wanninger, 2011, Journal of diabetes and its complications.

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver.

C. Buechler, Kristina Eisinger, T. Weiss, 2013, Experimental and molecular pathology.

Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo

Sabrina Bauer, C. Buechler, Kristina Eisinger, 2012, European journal of clinical investigation.

Intracellular survival of Staphylococcus aureus in adipocyte-like differentiated 3T3-L1 cells is glucose dependent and alters cytokine, chemokine, and adipokine secretion.

C. Buechler, W. Falk, B. Salzberger, 2011, Endocrinology.

Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes.

J. Schölmerich, A. Schäffler, M. Bala, 2010, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Short-term regulation of Visfatin release in vivo by oral lipid ingestion and in vitro by fatty acid stimulation.

A. Schmid, M. Bala, A. Kopp, 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Admission Visfatin Levels Predict Pancreatic and Peripancreatic Necrosis in Acute Pancreatitis and Correlate With Clinical Severity

J. Schölmerich, C. Buechler, H. Herfarth, 2011, The American Journal of Gastroenterology.

Admission Resistin Levels Predict Peripancreatic Necrosis and Clinical Severity in Acute Pancreatitis

J. Schölmerich, H. Herfarth, A. Schäffler, 2010, The American Journal of Gastroenterology.

C. Hofmann, W. Falk, F. Obermeier, 2011, Inflammatory bowel diseases.

Fatty acids as metabolic mediators in innate immunity

J. Schölmerich, C. Buechler, W. Falk, 2009, European journal of clinical investigation.

Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity

C. Buechler, M. Neumeier, E. Lieberer, 2009, European journal of clinical investigation.

C. Buechler, J. Schölmerich, M. Neumeier, 2010, Endocrinology.

Peritoneal fluid adipokines: ready for prime time?

C. Buechler, M. Neumeier, R. Wiest, 2009, European journal of clinical investigation.